Search

IRVINE: Helio Genomics, announces it will host a hybrid KOL event at Nasdaq MarketSite in New York on Monday, June 17, 2024, at 10:00 AM ET. To register, click here. [...]

IRVINE, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Helio Genomics ('Helio' or 'the Company'), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, today announced [...]

MORRISTOWN, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics [...]

SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, 'Aligos'), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical [...]

SINGAPORE: HistoIndex has issued the following news release: HistoIndex, a global leader in stain-free AI-powered digital pathology solutions, today announced its strong presence at the upcoming European Association for the [...]

MORRISTOWN, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics [...]

M2 EQUITYBITES-July 18, 2024-Medivir to present promising Fostrox data for liver lancer at ESMO Congress (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Swedish biotech company Medivir AB (STO:MVIR) announced on Thursday that updated [...]

M2 PHARMA-July 18, 2024-Medivir to present promising Fostrox data for liver lancer at ESMO Congress (C)2024 M2 COMMUNICATIONS Swedish biotech company Medivir AB (STO:MVIR) announced on Thursday that updated data [...]

NORDIC BUSINESS REPORT-July 18, 2024-Medivir to present promising Fostrox data for liver lancer at ESMO Congress (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Swedish biotech company Medivir AB (STO:MVIR) announced on Thursday that [...]

2024 JUN 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- HistoIndex, a global leader in stain-free AI-powered digital pathology solutions, announced its strong [...]

-- Late-breaking abstract on extended follow-up data from the MATCH Phase 2 trial accepted for poster presentation -- -- Poster presentation on new data highlighting the Company's discovery platform to [...]

SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver [...]

SINGAPORE: HistoIndex announced that the Company, alongside its collaborators, will present new data on its novel stain-free tissue imaging technology using clinically validated artificial intelligence (AI) algorithms at the EASL [...]

* New analysis demonstrates bilirubin normalization in PFIC patients treated with LIVMARLI (maralixibat); the only IBAT inhibitor reported to show this effect * Sleep improvement observed in patients with PFIC [...]

SOUTH SAN FRANCISCO: Assembly Biosciences, Inc. has issued the following news release: Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced [...]

SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced data from [...]

As part of school projects, discussion groups and free health checks for Viennese, the event, which WienTourismus and Messe Wien were able to win for their city, has an impact [...]

- Preclinical studies demonstrate rencofilstat may protect against NASH/NAFLD, shift the liver transcriptome and lipidome toward NASH resolution - - Cyclophilin B inhibition confirmed as an important target for treatment [...]

NEWARK: CymaBay Therapeutics has issued the following news release: CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with significant [...]

SAN FRANCISCO: Vir Biotechnology, Inc. has issued the following news release: Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that five abstracts highlighting new data from the Company's broad hepatitis portfolio [...]

SAN FRANCISCO: 89bio, Inc has issued the following news release: 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment [...]

Calif: Assembly Biosciences, Inc. has issued the following news release: Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that the [...]

-- International Herpesvirus Workshop will feature oral and poster presentations of preclinical data from ABI-5366, Assembly Bio's first herpesvirus development candidate -- -- Five posters accepted for presentation at EASL [...]

SAN FRANCISCO, June 07, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver [...]

SAN FRANCISCO, June 07, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that five abstracts highlighting new data from the Company's broad hepatitis portfolio addressing both hepatitis [...]

Two abstracts focus on the unique mechanism of action of seladelpar; a third focuses on characterizing patient risk of PBC disease progression NEWARK, Calif., June 7, 2023 /PRNewswire/ -- CymaBay [...]

London: King's College London has issued the following news release: Expert researchers and clinicians have been raising awareness about the importance of liver health in Parliament by hosting a liver [...]

M2 PRESSWIRE-January 17, 2023-: MPs invited to get their livers checked in Parliament during Love Your Liver Awareness Month (C)1994-2023 M2 COMMUNICATIONS RDATE:17012023 The nation's leading liver charity will take [...]

SOUTH SAN FRANCISCO, Calif: Pliant Therapeutics, Inc., a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, announced the presentation of two scientific [...]

SOUTH SAN FRANCISCO, Jun 24, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:PLRX ), EQNX::TICKER_END Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing [...]

NEWARK, Jun 22, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:CBAY), EQNX::TICKER_END CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic [...]

MORRISTOWN, Jun 21, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:ICPT), EQNX::TICKER_END Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat [...]

France: INVENTIVA has issued the following news release: Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment [...]

GSK plc will present 12 abstracts at the European Association for the Study of the Livers International Liver Congress 2022, taking place on June 22-26 in London. GSKs presence will [...]

GAITHERSBURG, Jun 17, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NasdaqGM:ALT), EQNX::TICKER_END Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Stephen A. Harrison, Medical Director, Pinnacle [...]

(GLOBE NEWSWIRE via COMTEX) -- - Update on Inventiva's NATiV3 Phase III clinical trial evaluating lanifibranor in patients with NASH and fibrosis (stage F2/F3) non-cirrhotic by Prof. Sven Francque - [...]

M2 PRESSWIRE-June 16, 2022-: GSK to present new data from the B-Clear phase IIb trial for bepirovirsen in chronic hepatitis B at the International Liver Congress 2022 (C)1994-2022 M2 COMMUNICATIONS [...]

SOUTH SAN FRANCISCO, Jun 15, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:PLRX ), EQNX::TICKER_END Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing [...]

Brentford, London, United: GlaxoSmithKline has issued the following press release: GSK plc will present 12 abstracts at the European Association for the Study of the Liver's International Liver Congress 2022, [...]

NEWARK, Calif: CymaBay Therapeutics, Inc has issued the following news release: CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases [...]

NEWARK, Jun 08, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:CBAY), EQNX::TICKER_END CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic [...]

WARMINSTER, Jun 08, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:ABUS), EQNX::TICKER_END Conference Call & Webcast to discuss new data being presented at EASL ILC 2022 scheduled for June 27, [...]

With clinical utilization at 8 U.S. Liver Transplant Centers since commercial introduction in January 2022, Paragonix recently showcased its donor liver technology at the 2022 American Transplant Congress CAMBRIDGE, Mass. [...]

SUWON, South Korea -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced that Behfar Ardehali, Ph.D., Senior Scientist of the Company, presented at the 7th Annual [...]

GAITHERSBURG: Sirnaomics Ltd. has issued the following news release: Sirnaomics Ltd. ('Sirnaomics', stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it [...]

Sirnaomics CTO Dmitry Samarsky, PhD, to Also Present OPT Congress Opening Remarks GAITHERSBURG, Md. and SUZHOU, China, March 14, 2022 /PRNewwire/ -- Sirnaomics Ltd. ('Sirnaomics ', stock code: 2257.HK), a [...]

U.S. Senator Todd Young (R-Ind.) recently joined a group of Republican senators in sending a letter to Department of Health and Human Services (HHS) Secretary Xavier Becerra urging the administration [...]

WASHINGTON -- The following information was released by Mississippi Senator Roger Wicker: U.S. Senators Roger Wicker, R-Miss., and Cindy Hyde-Smith, R-Miss.. have joined 14 colleagues to pressure Health and Human [...]

WASHINGTON -- The following information was released by Kansas Senator Jerry Moran: U.S. Senators Jerry Moran (Kan.) and Roy Blunt (Mo.) this week led 14 of their colleagues in urging [...]